US Stock MarketDetailed Quotes

Apogee Therapeutics (APGE)

Watchlist
  • 69.330
  • -10.530-13.19%
Trading Jan 23 12:25 ET
4.74BMarket Cap-15.83P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apogee Therapeutics (APGE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
21.46%71.28M
65.82%73.17M
65.25%63.1M
133.19%216.87M
104.23%75.88M
141.46%58.69M
133.64%44.12M
201.64%38.18M
202.68%93M
163.53%37.16M
Selling and administrative expenses
29.27%16.77M
56.99%17.14M
75.02%16.57M
99.38%49.01M
90.85%15.65M
79.27%12.97M
121.02%10.92M
125.20%9.47M
735.74%24.58M
333.69%8.2M
-General and administrative expense
29.27%16.77M
56.99%17.14M
75.02%16.57M
99.38%49.01M
90.85%15.65M
79.27%12.97M
121.02%10.92M
125.20%9.47M
735.74%24.58M
333.69%8.2M
Research and development costs
18.52%54.18M
67.75%55.7M
61.54%46.39M
145.33%167.87M
108.02%60.23M
167.82%45.71M
138.10%33.21M
239.63%28.72M
146.25%68.42M
137.17%28.95M
Depreciation amortization depletion
--331K
--325K
--143K
----
----
--0
--0
--0
----
----
-Depreciation and amortization
--331K
--325K
--143K
----
----
--0
--0
--0
----
----
Operating profit
-21.46%-71.28M
-65.82%-73.17M
-65.25%-63.1M
-133.19%-216.87M
-104.23%-75.88M
-141.46%-58.69M
-133.64%-44.12M
-201.64%-38.18M
-202.68%-93M
-163.53%-37.16M
Net non-operating interest income expense
-34.65%6.32M
-30.71%7.14M
28.80%7.84M
285.25%34.74M
60.17%8.68M
179.02%9.67M
10.31M
4,476.69%6.09M
199.56%9.02M
5,791.30%5.42M
Non-operating interest income
-34.65%6.32M
-30.71%7.14M
28.80%7.84M
285.25%34.74M
60.17%8.68M
179.02%9.67M
--10.31M
4,476.69%6.09M
9,702.17%9.02M
5,791.30%5.42M
Other net income (expense)
Income before tax
-32.52%-64.96M
-95.24%-66.02M
-72.17%-55.26M
-116.86%-182.13M
-111.75%-67.2M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
Income tax
61K
72K
83K
18K
18K
0
0
0
0
Net income
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
Net income continuous Operations
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
Minority interest income
Net income attributable to the parent company
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
Basic earnings per share
-29.07%-1.11
-88.33%-1.13
-48.44%-0.95
1.79%-3.3
-81.94%-1.19
-68.63%-0.86
-51.28%-0.6
-39.23%-0.64
-130.11%-3.36
-27.23%-0.6541
Diluted earnings per share
-29.07%-1.11
-88.33%-1.13
-48.44%-0.95
1.79%-3.3
-81.94%-1.19
-68.63%-0.86
-51.28%-0.6
-39.23%-0.64
-130.11%-3.36
-27.23%-0.6541
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 21.46%71.28M65.82%73.17M65.25%63.1M133.19%216.87M104.23%75.88M141.46%58.69M133.64%44.12M201.64%38.18M202.68%93M163.53%37.16M
Selling and administrative expenses 29.27%16.77M56.99%17.14M75.02%16.57M99.38%49.01M90.85%15.65M79.27%12.97M121.02%10.92M125.20%9.47M735.74%24.58M333.69%8.2M
-General and administrative expense 29.27%16.77M56.99%17.14M75.02%16.57M99.38%49.01M90.85%15.65M79.27%12.97M121.02%10.92M125.20%9.47M735.74%24.58M333.69%8.2M
Research and development costs 18.52%54.18M67.75%55.7M61.54%46.39M145.33%167.87M108.02%60.23M167.82%45.71M138.10%33.21M239.63%28.72M146.25%68.42M137.17%28.95M
Depreciation amortization depletion --331K--325K--143K----------0--0--0--------
-Depreciation and amortization --331K--325K--143K----------0--0--0--------
Operating profit -21.46%-71.28M-65.82%-73.17M-65.25%-63.1M-133.19%-216.87M-104.23%-75.88M-141.46%-58.69M-133.64%-44.12M-201.64%-38.18M-202.68%-93M-163.53%-37.16M
Net non-operating interest income expense -34.65%6.32M-30.71%7.14M28.80%7.84M285.25%34.74M60.17%8.68M179.02%9.67M10.31M4,476.69%6.09M199.56%9.02M5,791.30%5.42M
Non-operating interest income -34.65%6.32M-30.71%7.14M28.80%7.84M285.25%34.74M60.17%8.68M179.02%9.67M--10.31M4,476.69%6.09M9,702.17%9.02M5,791.30%5.42M
Other net income (expense)
Income before tax -32.52%-64.96M-95.24%-66.02M-72.17%-55.26M-116.86%-182.13M-111.75%-67.2M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M
Income tax 61K72K83K18K18K0000
Net income -32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M
Net income continuous Operations -32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M
Minority interest income
Net income attributable to the parent company -32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M
Basic earnings per share -29.07%-1.11-88.33%-1.13-48.44%-0.951.79%-3.3-81.94%-1.19-68.63%-0.86-51.28%-0.6-39.23%-0.64-130.11%-3.36-27.23%-0.6541
Diluted earnings per share -29.07%-1.11-88.33%-1.13-48.44%-0.951.79%-3.3-81.94%-1.19-68.63%-0.86-51.28%-0.6-39.23%-0.64-130.11%-3.36-27.23%-0.6541
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +3.98%
Sample Name
Sample Code
 +2.83%
4
Amazon
AMZN
+2.34%
5
NVIDIA
NVDA
+1.55%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +8.84%
Sample Name
Sample Code
 +5.04%
4
KE Holdings
BEKE
+4.44%
5
H World Group
HTHT
+4.03%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -